Upregulation of Fas/Fas ligand‐mediated apoptosis by gossypol in an immortalized human alveolar lung cancer cell line
- 1 October 2004
- journal article
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 31 (10), 716-722
- https://doi.org/10.1111/j.1440-1681.2004.04078.x
Abstract
Gossypol has wide antineoplastic effects in vitro, but its effects on human lung cancer have not been explored. To evaluate the activity of gossypol against alveolar cell lung cancer and to provide information on the mechanism of action, we examined the effects of gossypol on the proliferation of A549 cells indirectly using an XTT assay and on the distribution of cells within the phases of the cell cycle using flow cytometry. We also examined several factors that may affect apoptosis, including p53, p21/WAF1, Fas receptor, Fas ligand (FasL) and caspase 8 activity. The results showed that gossypol inhibited proliferation of A549 cells at a concentration of 0.5 micromol/L after 12 h treatment. The effect was both dose- and time-dependent by the induction of apoptosis without the effect of p53 and p21/WAF1. Upregulation of Fas/FasL, in association with the activation of downstream caspase 8 activity, was observed following treatment with gossypol. The Fas/FasL pathway accounted for 75% of gossypol-mediated apoptosis. We suggest that the Fas/FasL apoptotic system is the major pathway for gossypol-mediated apoptosis of A549 cells. Gossypol had no effect on the distribution of A549 cells within the phases of the cell cycle. In conclusion, gossypol inhibited A549 cells mainly by induction of the Fas/FasL apoptotic pathway, but not the p53 and p21/WAF1 pathway.Keywords
This publication has 42 references indexed in Scilit:
- Cytotoxic effect of gossypol on colon carcinoma cellsLife Sciences, 2000
- Melatonin increases p53 and p21WAFl expression in MCF-7 human breast cancer cells in vitroLife Sciences, 1999
- Apoptosis by Death FactorCell, 1997
- Inhibition of human prostate cancer cells growth by gossypol is associated with stimulation of transforming growth factor-βCancer Letters, 1996
- Apoptosis in the Pathogenesis and Treatment of DiseaseScience, 1995
- Presence of antitumor activities in the milk collected from gossypol-treated dairy cowsCancer Letters, 1994
- Gossypol in hibits basal and estrogen-stimulated DNA synthesis in human breast carcinoma cellsLife Sciences, 1993
- An Overview of the Clinical Pharmacology and Therapeutic Potential of Gossypol as a Male Contraceptive Agent and in Gynaecological DiseaseDrugs, 1989
- Gossypol, a potent inhibitor of arachidonate 5- and 12-lipoxygenasesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1985
- Male "Pill" Blocks Sperm EnzymeScience, 1981